Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
- PMID: 16950834
- PMCID: PMC1569956
- DOI: 10.1136/bmj.38933.585764.AE
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
Abstract
Objective: To delineate the risk factors, symptom patterns, and longitudinal course of prolonged illnesses after a variety of acute infections.
Design: Prospective cohort study following patients from the time of acute infection with Epstein-Barr virus (glandular fever), Coxiella burnetii (Q fever), or Ross River virus (epidemic polyarthritis).
Setting: The region surrounding the township of Dubbo in rural Australia, encompassing a 200 km geographical radius and 104,400 residents.
Participants: 253 patients enrolled and followed at regular intervals over 12 months by self report, structured interview, and clinical assessment.
Outcome measures: Detailed medical, psychiatric, and laboratory evaluations at six months to apply diagnostic criteria for chronic fatigue syndrome. Premorbid and intercurrent illness characteristics recorded to define risk factors for chronic fatigue syndrome. Self reported illness phenotypes compared between infective groups.
Results: Prolonged illness characterised by disabling fatigue, musculoskeletal pain, neurocognitive difficulties, and mood disturbance was evident in 29 (12%) of 253 participants at six months, of whom 28 (11%) met the diagnostic criteria for chronic fatigue syndrome. This post-infective fatigue syndrome phenotype was stereotyped and occurred at a similar incidence after each infection. The syndrome was predicted largely by the severity of the acute illness rather than by demographic, psychological, or microbiological factors.
Conclusions: A relatively uniform post-infective fatigue syndrome persists in a significant minority of patients for six months or more after clinical infection with several different viral and non-viral micro-organisms. Post-infective fatigue syndrome is a valid illness model for investigating one pathophysiological pathway to chronic fatigue syndrome.
Figures
Similar articles
-
Predictors of Chronic Fatigue Syndrome and Mood Disturbance After Acute Infection.Front Neurol. 2022 Jul 25;13:935442. doi: 10.3389/fneur.2022.935442. eCollection 2022. Front Neurol. 2022. PMID: 35959390 Free PMC article.
-
Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever.Br J Psychiatry. 1998 Dec;173:475-81. doi: 10.1192/bjp.173.6.475. Br J Psychiatry. 1998. PMID: 9926075
-
Contribution of individual psychological and psychosocial factors to symptom severity and time-to-recovery after naturally-occurring acute infective illness: The Dubbo Infection Outcomes Study (DIOS).Brain Behav Immun. 2019 Nov;82:76-83. doi: 10.1016/j.bbi.2019.07.034. Epub 2019 Jul 31. Brain Behav Immun. 2019. PMID: 31376496
-
Antibodies to Epstein-Barr virus in patients with chronic fatigue.South Med J. 1991 Jul;84(7):832-40. doi: 10.1097/00007611-199107000-00005. South Med J. 1991. PMID: 1648795 Review.
-
Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.QJM. 2009 Oct;102(10):673-84. doi: 10.1093/qjmed/hcp077. Epub 2009 Jun 25. QJM. 2009. PMID: 19556396 Review.
Cited by
-
Advance in the mechanism and clinical research of myalgia in long COVID.Am J Clin Exp Immunol. 2024 Aug 25;13(4):142-164. doi: 10.62347/TXVO6284. eCollection 2024. Am J Clin Exp Immunol. 2024. PMID: 39310121 Free PMC article. Review.
-
Persistent Borrelia burgdorferi Sensu Lato Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models.Clin Microbiol Rev. 2022 Dec 21;35(4):e0007422. doi: 10.1128/cmr.00074-22. Epub 2022 Oct 12. Clin Microbiol Rev. 2022. PMID: 36222707 Free PMC article. Review.
-
Three Cases of Severe ME/CFS in Adults.Healthcare (Basel). 2021 Feb 16;9(2):215. doi: 10.3390/healthcare9020215. Healthcare (Basel). 2021. PMID: 33669438 Free PMC article.
-
Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis.Immunol Res. 2013 Jul;56(2-3):398-412. doi: 10.1007/s12026-013-8413-z. Immunol Res. 2013. PMID: 23576059
-
Long COVID-19 and Coexistence of Fatigue and Depression: A Cross-sectional Study from Saudi Arabia.J Epidemiol Glob Health. 2024 Dec;14(4):1602-1608. doi: 10.1007/s44197-024-00312-7. Epub 2024 Oct 14. J Epidemiol Glob Health. 2024. PMID: 39400651 Free PMC article.
References
-
- Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121: 953-9. - PubMed
-
- Royal Australasian College of Physicians Working Group. Chronic fatigue syndrome—clinical practice guidelines 2002. Med J Aust 2002;176: S17-55. - PubMed
-
- Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003;160: 221-36. - PubMed
-
- Gold D, Bowden R, Sixbey J, Riggs R, Katon WJ, Ashley R, et al. Chronic fatigue: a prospective clinical and virologic study. JAMA 1990;264: 48-53. - PubMed
-
- Heneine W, Woods TC, Sinha SD, Khan AS, Chapman LE, Schonberger LB, et al. Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome. Clin Infect Dis 1994;18(suppl 1): S121-5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous